Leadership

Board of Directors
Executive Committee
Finance Committee
Governance Committee
NCCN Foundation Board of Directors
Management Team

NCCN Board of Directors

The NCCN Board of Directors is comprised of two representatives from each NCCN Member Institution who share in NCCN's mission to improve and facilitate quality, effective, equitable, and accessible cancer care so all patients can live better lives.

Matt Kalaycio, MD / Chair
Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
Christopher H. Lieu, MD / Vice-Chair
University of Colorado Cancer Center
Patrick J. O'Brien, MBA / Treasurer
Fox Chase Cancer Center
Maria M. Gonzalez, MPH, BS / Secretary
Stanford Cancer Institute
Edwin P. Alyea III, MD
Duke Cancer Institute
Sachin M. Apte, MD, MBA, MS
Huntsman Cancer Institute at the University of Utah
Carlos L. Arteaga, MD
UT Southwestern Simmons Comprehensive Cancer Center
James E. Bachman, MPA
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Al B. Benson III, MD, FACCC, FACP, FASCO
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Rondeep Brar, MD
Stanford Cancer Institute
Laurel Bray-Hanin, MA
UCSF Helen Diller Family Comprehensive Cancer Center
Craig A. Bunnell, MD, MBA, MPH
Dana-Farber/Brigham and Women's Cancer Center | Mass General Cancer Center
Rebecca L. Caires, MBA
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
William E. Carson III, MD
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
Peter Connor, MS
University of Wisconsin Carbone Cancer Center
Gena Cook
NCCN Foundation Board of Directors
David T. Cooke, MD, FACS
UC Davis Comprehensive Cancer Center
Nancy E. Davidson, MD
Fred Hutchinson Cancer Center
Gina Dayton, MPA
UC Davis Comprehensive Cancer Center
Jordan M. DeMoss, MSHA
O'Neal Comprehensive Cancer Center at UAB
Timothy R. Donahue, MD
UCLA Jonsson Comprehensive Cancer Center
Timothy J. Eberlein, MD, FACS
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Stephen B. Edge, MD, FACS, FASCO
Roswell Park Comprehensive Cancer Center
Robin Famiglietti, PhD, MBA, FACHE
Duke Cancer Institute
Steven J. Frank, MD
The University of Texas MD Anderson Cancer Center
Laura W. Goff, MD, MSCI, MMHC
Vanderbilt-Ingram Cancer Center
Ayad Hamdan, MD
UC San Diego Moores Cancer Center
Barbara A. Jagels, RN, MHA, CPHQ
UCLA Jonsson Comprehensive Cancer Center
Kris M. Kipp, MSN, RN
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
Michael R. Kuettel, MD, PhD, MBA
Roswell Park Comprehensive Cancer Center
Kelvin P. Lee, MD
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Ashley B. Lee
City of Hope National Medical Center
Christi G. Longnecker, BSN, MBA, RN, JD
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Cynthia McCollum, MBA
Memorial Sloan Kettering Cancer Center
Brittany McCreery, MD, MBA
Fred Hutchinson Cancer Center
Katie McGill, MSM
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Robert R. McWilliams, MD, MSc, MSHA
Mayo Clinic Comprehensive Cancer Center
David B. Miller, MBA
Abramson Cancer Center at the University of Pennsylvania
Donald F. Milligan, MBA
Huntsman Cancer Institute at the University of Utah
Lisle M. Nabell, MD
O'Neal Comprehensive Cancer Center at UAB
Alberto S. Pappo, MD
St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
David G. Pfister, MD
Memorial Sloan Kettering Cancer Center
Lori C. Pickens, MHA
Yale Cancer Center/Smilow Cancer Hospital
Elizabeth R. Plimack, MD, MS
Fox Chase Cancer Center
Mitchell C. Posner, MD, FACS
The UChicago Medicine Comprehensive Cancer Center
Ravi Salgia, MD, PhD
City of Hope National Medical Center
Theresa Sberna, MPH
Vanderbilt-Ingram Cancer Center
Bryan J. Schneider, MD
University of Michigan Rogel Cancer Center
Richard D. Schulick, MD, MBA, FACS
University of Colorado Cancer Center
David Shibata, MD, FACS, FASCRS
St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
Diane M. Simeone, MD
UC San Diego Moores Cancer Center
Kyle F. Skiermont, PharmD
Fred & Pamela Buffett Cancer Center
David C. Smith, MD
University of Michigan Rogel Cancer Center
Beth A. Souza, MS
Dana-Farber/Brigham and Women's Cancer Center | Mass General Cancer Center
Philippe E. Spiess, MD, MS, FRCS, FACS
Moffitt Cancer Center
Jolene Summer Bolster
Mayo Clinic Comprehensive Cancer Center
Kyle A. Taylor, MHSA, CPHQ
UT Southwestern Simmons Comprehensive Cancer Center
Theodoros Teknos, MD
Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
Yvette Tremonti, CPA, MBA
Moffitt Cancer Center
Alan P. Venook, MD
UCSF Helen Diller Family Comprehensive Cancer Center
Robert H. Vonderheide, MD, DPhil
Abramson Cancer Center at the University of Pennsylvania
Julie M. Vose, MD, MBA
Fred & Pamela Buffett Cancer Center
Lauren Wall, MS
The UChicago Medicine Comprehensive Cancer Center
Ronald S. Walters, MD, MBA, MS, MHA
The University of Texas MD Anderson Cancer Center
Lee G. Wilke, MD, FACS
University of Wisconsin Carbone Cancer Center
Eric P. Winer, MD
Yale Cancer Center/Smilow Cancer Hospital

Executive Committee

Matt Kalaycio, MD / Chair
Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
Al B. Benson III, MD, FACCC, FACP, FASCO
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Nancy E. Davidson, MD
Fred Hutchinson Cancer Center
Laura W. Goff, MD, MSCI, MMHC
Vanderbilt-Ingram Cancer Center
Maria M. Gonzalez, MPH, BS
Stanford Cancer Institute
Barbara A. Jagels, RN, MHA, CPHQ
UCLA Jonsson Comprehensive Cancer Center
Christopher H. Lieu, MD
University of Colorado Cancer Center
Patrick J. O'Brien, MBA
Fox Chase Cancer Center
Yvette Tremonti, CPA, MBA
Moffitt Cancer Center
Ronald S. Walters, MD, MBA, MS, MHA
The University of Texas MD Anderson Cancer Center

Finance Committee

Patrick J. O'Brien, MBA / Chair
Fox Chase Cancer Center
James E. Bachman, MPA
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Robin Famiglietti, PhD, MBA, FACHE
Duke Cancer Institute
Katie McGill, MSM
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Robert R. McWilliams, MD, MSHA, MSc
Mayo Clinic Comprehensive Cancer Center

Governance Committee

Christopher H. Lieu, MD / Chair
University of Colorado Cancer Center
Timothy J. Eberlein, MD, FACS
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Maria M. Gonzalez, MPH, BS
Stanford Cancer Institute
Matt Kalaycio, MD
Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
Ashley B. Lee
City of Hope National Medical Center
Kelvin P. Lee, MD
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
David B. Miller, MBA
Abramson Cancer Center at the University of Pennsylvania
Patrick J. O'Brien, MBA
Fox Chase Cancer Center

Foundation Board of Directors

Gena Cook / Chair
Kaliper Health
Heather J. hkopecky, PhD, MBA / Vice-Chair
Korn Ferry International
Patrick J. O'Brien, MBA / Treasurer
Fox Chase Cancer Center
Angelique L. Richard, PhD, RN / Secretary
Rush University Medical Center
Al B. Benson III, MD, FACCC, FACP, FASCO
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Patrick Delaney
NCCN Foundation
Crystal S. Denlinger, MD
National Comprehensive Cancer Network
Denise Portner
SteegeThomson Communications
Christopher Price
Epilog Partners, LP
Marc Samuels, JD, MPH
ADVI
Susan Stein, MPH
SCS Health Solutions
Tamar Thompson
Alexion AstraZeneca Rare Disease

NCCN Senior Management Team

Crystal S. Denlinger, MD, is the Chief Executive Officer (CEO) at the National Comprehensive Cancer Network (NCCN). She joined NCCN in April 2021 as Senior Vice President, Chief Scientific Officer and was successfully recruited as CEO in 2023, following a national search. Dr. Denlinger oversees all NCCN programs and activities, including maintaining the library of NCCN Guidelines^® and advancing global collaborations, new oncology research, peer-reviewed publication, patient information, and cancer policy.

Prior to joining NCCN, Dr. Denlinger held several leadership positions with Fox Chase Cancer Center—an NCCN Member Institution—including Chief, Gastrointestinal Medical Oncology; Deputy Director, Early Drug Development Phase 1 Program; Director, Survivorship Program; and Associate Professor, Department of Hematology/Oncology. After joining NCCN, she will continue to see patients at Fox Chase Cancer Center in a limited, volunteer capacity.

Dr. Denlinger has been involved with NCCN for many years, including serving as chair of the NCCN Guidelines Panel for Survivorship and serving on a number of panels, including the Esophageal/Gastric Cancers Panel, the JNCCN—Journal of the National Comprehensive Cancer Network Editorial Board, and on various abstract committees and ORP RFP committees, including chairing two committees. She was named an NCCN Young Investigator Awardee in 2012 and received the NCCN Rodger Winn Award in 2018 for exemplifying leadership, drive, and commitment in service to developing clinical practice guidelines.

She graduated from a combined BS/MD program at The College of New Jersey and Rutgers New Jersey Medical School, followed by an internal medicine residency with Mount Sinai Medical Center, and hematology/oncology fellowship at Fox Chase Cancer Center/Temple University Hospital. She has authored hundreds of clinical research articles and abstracts and received awards from organizations that include the American Society of Clinical Oncology (ASCO) Foundation and the American College of Physicians.
Gary J. Weyhmuller, MBA, SPHR, is the Executive Vice President/Chief Operating Officer (EVP/COO) at the National Comprehensive Cancer Network (NCCN). Mr. Weyhmuller joined NCCN as EVP/COO in February 2014. Working closely with the CEO, he is responsible for providing leadership and management to NCCN Staff, helping to assure the development of new programs, as well as the continued efficient and effective operations of existing programs for NCCN Member Institutions and other constituencies.

Mr. Weyhmuller comes to NCCN with more than 35 years of experience at Fox Chase Cancer Center, most recently serving as Senior Vice President and Chief Operating Officer, responsible for leadership and oversight of the daily operations supporting all research, clinical, and operational activities for more than 2,400 employees. Prior to this role as SVP/COO, Mr. Weyhmuller held several other leadership roles within Fox Chase, including Vice President of Human Resources and Chief Administrative Officer.

Mr. Weyhmuller holds a Master of Business Administration from LaSalle University and a Bachelor of Science in education, political science, and minority studies from West Chester University. He also holds a certification as Senior Professional in Human Resources (SPHR) from Villanova University.

Outside of his professional career Mr. Weyhmuller demonstrates an active history of community service. Currently he is Vice Chair of the Board of Directors for American Heritage Federal Credit Union and a member of the Board of Directors for United Cerebral Palsy of Philadelphia and Vicinity, where he served as President of the Board from 2008 through 2011.

Mr. Weyhmuller is active in a number of professional organizations including the Healthcare Financial Management Association (HFMA), the American Hospital Association (AHA), the Association of American Cancer Institutes (AACI), and the Society for Human Resource Management (SHRM). He has been recognized for his leadership, both professionally and through his community service, including the Fox Chase Cancer Center Inspired Leadership Award, recognition for leadership and personal dedication on behalf of people with disabilities from United Cerebral Palsy of Philadelphia and Vicinity, and the Greater Northeast Philadelphia Chamber of Commerce Crystal Vision Award.
Wui-Jin Koh, MD, is the Senior Vice President/Chief Medical Officer at the National Comprehensive Cancer Network (NCCN). In this role, he helps oversee the flagship NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) program. In addition, he is responsible for medical leadership and oversight for NCCN’s continuing medical education program and JNCCN — Journal of the National Comprehensive Cancer Network, and represents the organization at clinical and scientific meetings. He is also actively involved in the NCCN Global initiatives.

Prior to joining NCCN in 2018, he served as Professor of Radiation Oncology at University of Washington and Medical Director for Radiation Oncology at Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.

Dr. Koh earned his medical degree at Loma Linda University School of Medicine. He conducted his post-graduate training at the University of Washington Medical Center, completing a residency in radiation oncology and a clinical fellowship in metabolic tumor imaging. He is board-certified in radiation oncology.

Dr. Koh’s research interests include combined chemo-radiation strategies, cancer management guidelines development, and the role of imaging in radiotherapy and cancer care. He specialized in the management of gynecologic and gastrointestinal tract tumors and the use of brachytherapy and intraoperative radiotherapy. He has received multiple Educator and National Top Doctors awards.

Dr. Koh is well-published and involved in numerous professional societies, including the Society of Gynecologic Oncology, the American Society of Clinical Oncology, the NRG-Oncology Clinical Trials Cooperative Group, the Western Association of Gynecologic Oncology, and the International Gynecologic Cancer Society. He also served as a member of the NCI Gynecologic Cancer Steering Committee from 2007-2015.
Eileen C. Boscia, CPA, MBA, is Vice President, Chief Financial Officer at the National Comprehensive Cancer Network (NCCN). Ms. Boscia joined NCCN in 2009 and is responsible for all aspects of financial accountability for NCCN and the NCCN Foundation including receivables, payables, financial reporting, internal controls, cash and investment management, and coordination of year-end audits for NCCN and NCCN Foundation. She is also responsible for risk management and compliance as well as review of legal, financial and other business issues concerning NCCN and the NCCN Foundation. She is responsible for providing financial and other analyses for strategic planning purposes.

Prior to working with NCCN, Ms. Boscia worked with a regional accounting firm performing audit, tax, accounting, and consulting services for small to mid-sized clients in a variety of industries including not-for-profits. She is a member of both the American Institution of Certified Public Accountants (AICPA) and the Pennsylvania Institute of Certified Public Accountants (PICPA).

Ms. Boscia has a Bachelor of Science in Accounting from the University of Delaware and a Master of Business Administration with a concentration in Management Information Systems from LaSalle University. She is also licensed as a Certified Public Accountant in Pennsylvania.
Kristina M. Gregory, RN, MSN, is Senior Vice President of Clinical Information Programs at the National Comprehensive Cancer Network (NCCN).
In this role, Ms. Gregory is responsible for the overall operations of the NCCN Guidelines Program.
Prior to working with NCCN, Ms. Gregory served as a Health Management Program Coordinator at Independence Blue Cross and was also a staff nurse at Fox Chase Cancer Center.
Ms. Gregory has a Master’s in Public Health Nursing from LaSalle University and a Bachelor of Science in Nursing from the University of Pennsylvania.
Jennifer Tredwell, MBA, is Vice President of Marketing & Communications at NCCN. In this role, Ms. Tredwell is responsible for the NCCN brand, website content, and strategic marketing plans of all programs and projects. She develops marketing and branding strategies for NCCN events, resources, publications, mobile apps, online learning, and research programs. She oversees the production of multi-channel digital and traditional marketing campaigns and is responsible for fundraising in the areas of sponsorships, exhibits, and advertising.

Prior to joining NCCN as full-time employee in 2005, Ms. Tredwell consulted for NCCN as well as a number of other health care organizations, including The Children’s Hospital of Philadelphia, Albert Einstein Healthcare Network, Moss Rehab, Beebe Medical Center, and The National Spine Network. She also worked for OneBeacon Insurance where she held a range of responsibilities in marketing and communications.

Ms. Tredwell received a Master of Business Administration from Temple University and a Bachelor of Arts from Syracuse University.
Beth Gaffney, MBA, is Vice President of U.S. and Global Business Development at NCCN. In this role, Ms. Gaffney oversees both U.S. and global business activities and the development of the NCCN brand worldwide. She helps ensure the influence of NCCN content and the ongoing collaboration and support of all stakeholders. She leads multiple functional areas across the organization, including business development (U.S. and global), business insights, commercial licensing, health information technology collaborations, and payer and employer outreach. She also works closely with NCCN’s marketing and communications department and oncology policy program.

Prior to joining NCCN, Ms. Gaffney led strategic business development for risk management and patient support services for United BioSource LLC. She also previously held positions with Johnson & Johnson’s McNeil Consumer Healthcare division and Men’s Health Magazine.

Ms. Gaffney received a Master of Business Administration from The Wharton School of the University of Pennsylvania and a Bachelor of Arts in International Relations from St. Joseph’s University.